Principal Financial Group
NTLA icon

Principal Financial Group’s Intellia Therapeutics NTLA Stock Holding History

Principal Financial Group’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,860
Closed -$288K – 2351
2024
Q2 		$288K Sell
12,860
-7,691
-37% -$183K ﹤0.01% 2064
2024
Q1 		$565K Sell
20,551
-1,293
-6% -$35.9K ﹤0.01% 1961
2023
Q4 		$666K Sell
21,844
-2,121
-9% -$61K ﹤0.01% 1895
2023
Q3 		$758K Buy
23,965
+3,440
+17% +$133K ﹤0.01% 1878
2023
Q2 		$837K Buy
20,525
+721
+4% +$29.2K ﹤0.01% 1867
2023
Q1 		$738K Sell
19,804
-31
-0.2% -$1.22K ﹤0.01% 1903
2022
Q4 		$692K Buy
19,835
+1,253
+7% +$59.6K ﹤0.01% 1911
2022
Q3 		$1.04M Buy
18,582
+1,035
+6% +$64.2K ﹤0.01% 1834
2022
Q2 		$908K Sell
17,547
-8,123
-32% -$412K ﹤0.01% 1936
2022
Q1 		$1.86M Sell
25,670
-2,705
-10% -$229K ﹤0.01% 1871
2021
Q4 		$3.35M Sell
28,375
-93,053
-77% -$11.7M ﹤0.01% 1775
2021
Q3 		$16.3M Buy
121,428
+6,823
+6% +$1.03M 0.01% 1100
2021
Q2 		$18.6M Buy
114,605
+89,624
+359% +$6.98M 0.01% 1036
2021
Q1 		$2M Buy
24,981
+157
+0.6% +$10.5K ﹤0.01% 1851
2020
Q4 		$1.35M Buy
+24,824
New +$901K ﹤0.01% 1875
2020
Q3 		– Sell
-10,437
Closed -$219K – 2340
2020
Q2 		$219K Buy
+10,437
New +$177K ﹤0.01% 2169

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Principal Financial Group's NTLA Position: Q3 2024 in Review

Principal Financial Group sold out of Intellia Therapeutics (NTLA) in Q3 2024, closing a stake of 12,860 shares — an estimated $288K sold.

Principal Financial Group first reported a position in NTLA in Q2 2020 and held it in 16 quarters. The position peaked at $18.6M in Q2 2021. 283 funds tracked by Wall St. Rank hold NTLA as of Q3 2024.

  • Principal Financial Group reported no remaining Intellia Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Principal Financial Group sold 12,860 Intellia Therapeutics shares in Q3 2024, an estimated $288K.
  • Principal Financial Group first reported a position in Intellia Therapeutics in Q2 2020 and held it in 16 quarters.
  • Principal Financial Group's Intellia Therapeutics position peaked at $18.6M in Q2 2021.
  • 283 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2024.

Based on Principal Financial Group's 13F filing for Q3 2024, filed 31 Oct 2024.